drugset / Trial / NCT05901467
Recall by Genotype: Neuropeptide Stimulation
NaSingle-groupOpen-labelOther
Summary
The objective of this protocol is to assess response to kisspeptin and gonadotropin-releasing hormone (GnRH) stimulation testing as well as the baseline patterns of luteinizing hormone (LH) secretion in individuals who carry variants in genes related to infertility.
Timeline
- Start
- 2023-10-20
- Primary completion
- 2024-05-29
- Completion
- 2024-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gonadorelin | Protein / enzyme biologic | — | Intravenous |
| Subject | kisspeptin 112-121 | Peptide | — | Intravenous |